Beta Bionics (BBNX) Share-based Compensation (2024 - 2026)

Beta Bionics has disclosed Share-based Compensation across 3 years of filings, most recently posting $5.4 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $5.4 million, up 92.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.0 million (up 142.45% YoY), and the FY2025 annual result was $16.4 million, up 156.64% from the prior year.
• Share-based Compensation came in at $5.4 million for Q1 2026 at Beta Bionics, up from $4.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.4 million in Q1 2026 to a low of $1.4 million in Q1 2024.
• The 3-year median for Share-based Compensation is $2.8 million (2025), against an average of $3.1 million.
• Across the five-year window, Share-based Compensation jumped 220.15% in 2025 and jumped 92.8% in 2026, its largest moves.
• Beta Bionics' Share-based Compensation stood at $1.6 million in 2024, then surged by 177.26% to $4.3 million in 2025, then climbed by 25.63% to $5.4 million in 2026.
• The last three Share-based Compensation figures came in at $5.4 million (Q1 2026), $4.3 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.